Tafero tablets composition includes Emtricitabine, a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Alafenamide, which delivers active tenofovir efficiently into cells with lower systemic exposure. This combination blocks the reverse transcriptase enzyme that HIV needs to multiply, thereby slowing disease progression and reducing the risk of transmission.
Tafero tablets uses include the treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy. In certain cases, it may also be used in HIV prevention strategies under medical guidance. Although it does not cure HIV, consistent use significantly improves quality of life and disease control.
Tafero tablets dosage is typically once daily or as directed by a healthcare professional. Patients must follow the prescribed regimen carefully and avoid missing doses to maintain effective viral suppression.
Tafero tablets side-effects may include nausea, headache, fatigue, diarrhea, or mild abdominal discomfort. These effects are usually temporary, but any severe symptoms should be reported to a doctor promptly.
Tafero tablets precautions include informing the healthcare provider about kidney or liver conditions, pregnancy, breastfeeding, or other medications. Tafero tablets interactions may occur with certain antivirals and prescription drugs, so medical supervision is essential. Tafero tablets substitutes may be available depending on clinical needs.
Tafero tablets reviews highlight their effectiveness and tolerability in long-term HIV management when used consistently under professional care.